Skip to main content
Top
Published in: BMC Geriatrics 1/2018

Open Access 01-12-2018 | Research article

Octo- and nonagenarians’ outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study

Authors: Ingela Thylén, Debra K. Moser, Anna Strömberg

Published in: BMC Geriatrics | Issue 1/2018

Login to get access

Abstract

Background

Elderly individuals are increasingly represented among patients with implantable cardioverter defibrillators (ICD), but data describing life with an ICD are scarse among octo- and nonagenarians. Moreover, few studies have reported those elderly patients’ perspective on timly discussions concerning what shock deactivation involves, preferences on battery replacement, and their attitudes about turning off the ICD nearing end-of-life. Consequently, the aim of the study was to describe outlooks on life and death in octo- and nonagenarian ICD-recipients.

Methods

Participants were identified via the Swedish Pacemaker- and ICD-registry, with 229 octo- and nonagenarians (82.0 ± 2.2 years, 12% female) completing the survey on one occasion. The survey involved questions on health and psychological measures, as well as on experiences, attitudes and knowledge of end-of-life issues in relation to the ICD.

Results

The majority (53%) reported their existing health as being good/very good and rated their health status as 67 ± 18 on the EuroQol Visual Analog Scale. A total of 34% had experienced shock(s), 11% suffered from symptoms of depression, 15% had anxiety, and 26% reported concerns related to their ICD. About one third (34%) had discussed their illness trajectory with their physician, with those octo- and nonagenarians being more decisive about a future deactivation (67% vs. 43%, p < .01). A minority (13%) had discussed what turning off shocks would involve with their physician, and just 7% had told their family their wishes about a possible deactivation in the future. The majority desired battery replacement even if they had reached a very advanced age when one was needed (69%), or were seriously ill with a life-threatening disease (55%). When asked about deactivation in an anticipated terminal illness, about one third (34%) stated that they wanted to keep the shocks in the ICD during these circumstances. About one-fourth of the octo- and nonagenarians had insufficient knowledge regarding the ethical aspects, function of the ICD, and practical consequences of withdrawing the ICD treatment in the end-of-life.

Conclusions

Increasing numbers of elderly persons receive an ICD and geriatric care must involve assessments of life expectancy as well as the patient’s knowledge and attitudes in relation to generator changes and deactivation.
Literature
1.
go back to reference Tracy CM, et al. 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6-e75.CrossRef Tracy CM, et al. 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6-e75.CrossRef
2.
go back to reference Epstein AE, et al. Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm. 2009;6(8):1136–43.CrossRef Epstein AE, et al. Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm. 2009;6(8):1136–43.CrossRef
3.
go back to reference Russo AM, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2013;61(12):1318–68.CrossRef Russo AM, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2013;61(12):1318–68.CrossRef
4.
go back to reference Kurtz SM, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol. 2010;33(6):705–11.CrossRef Kurtz SM, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol. 2010;33(6):705–11.CrossRef
5.
go back to reference Kinch Westerdahl A, et al. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life. Circulation. 2014;129(4):422–9.CrossRef Kinch Westerdahl A, et al. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life. Circulation. 2014;129(4):422–9.CrossRef
6.
go back to reference Merchant FM, et al. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. J Am Heart Assoc. 2014;3:e001289.PubMedPubMedCentral Merchant FM, et al. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. J Am Heart Assoc. 2014;3:e001289.PubMedPubMedCentral
7.
go back to reference van der Heijden AC, et al. The clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications. Heart Rhythm. 2015;12(6):1169–76.CrossRef van der Heijden AC, et al. The clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications. Heart Rhythm. 2015;12(6):1169–76.CrossRef
8.
go back to reference Erkapic D, et al. Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study. Eur Heart J. 2013;34(2):130–7.CrossRef Erkapic D, et al. Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study. Eur Heart J. 2013;34(2):130–7.CrossRef
10.
go back to reference Magyar-Russell G, et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res. 2011;71(4):223–31.CrossRef Magyar-Russell G, et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res. 2011;71(4):223–31.CrossRef
11.
go back to reference Padeletti L, et al. EHRA expert consensus statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace. 2010;12(10):1480–9.CrossRef Padeletti L, et al. EHRA expert consensus statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace. 2010;12(10):1480–9.CrossRef
12.
go back to reference Goldstein NE, Back AL, Morrison RS. Titrating guidance: a model to guide physicians in assisting patients and family members who are facing complex decisions. Arch Intern Med. 2008;168(16):1733–9.CrossRef Goldstein NE, Back AL, Morrison RS. Titrating guidance: a model to guide physicians in assisting patients and family members who are facing complex decisions. Arch Intern Med. 2008;168(16):1733–9.CrossRef
13.
go back to reference Lampert R, et al. HRS expert consensus statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7(7):1008–26.CrossRef Lampert R, et al. HRS expert consensus statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7(7):1008–26.CrossRef
15.
go back to reference Goldstein N, et al. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol. 2009;54(4):371–3.CrossRef Goldstein N, et al. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol. 2009;54(4):371–3.CrossRef
16.
go back to reference Stromberg A, et al. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life. Pacing Clin Electrophysiol. 2014;37(7):834–42.CrossRef Stromberg A, et al. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life. Pacing Clin Electrophysiol. 2014;37(7):834–42.CrossRef
17.
go back to reference Sherazi S, et al. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc. 2008;83(10):1139–41.CrossRef Sherazi S, et al. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc. 2008;83(10):1139–41.CrossRef
18.
go back to reference Kelley, A.S., et al., Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey. Am Heart J, 2009. 157(4): p. 702–8 e1.CrossRef Kelley, A.S., et al., Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey. Am Heart J, 2009. 157(4): p. 702–8 e1.CrossRef
19.
go back to reference Kinch Westerdahl A, Frykman V. Physicians’ knowledge of implantable defibrillator treatment: are we good enough? Europace. 2017;19(7):1163–9.CrossRef Kinch Westerdahl A, Frykman V. Physicians’ knowledge of implantable defibrillator treatment: are we good enough? Europace. 2017;19(7):1163–9.CrossRef
20.
go back to reference Russo JE. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes. Am J Nurs. 2011;111(10):26–35.PubMed Russo JE. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes. Am J Nurs. 2011;111(10):26–35.PubMed
21.
go back to reference Fluur C, et al. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues. Heart Lung. 2013;42(3):202–7.CrossRef Fluur C, et al. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues. Heart Lung. 2013;42(3):202–7.CrossRef
22.
go back to reference Herman D, et al. Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Europace. 2013;15(7):963–9.CrossRef Herman D, et al. Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Europace. 2013;15(7):963–9.CrossRef
23.
go back to reference Miller J, Thylen I, Moser DK. Gender disparities in symptoms of anxiety, depression, and quality of life in defibrillator recipients. Pacing Clin Electrophysiol. 2015;00:1–11. Miller J, Thylen I, Moser DK. Gender disparities in symptoms of anxiety, depression, and quality of life in defibrillator recipients. Pacing Clin Electrophysiol. 2015;00:1–11.
24.
go back to reference Thylen I, et al. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients. J Psychosom Res. 2014;77(2):122–7.CrossRef Thylen I, et al. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients. J Psychosom Res. 2014;77(2):122–7.CrossRef
26.
go back to reference EuroQol, G. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef EuroQol, G. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef
27.
go back to reference Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRef Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRef
28.
go back to reference Bjelland I, et al. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77.CrossRef Bjelland I, et al. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77.CrossRef
29.
go back to reference Pedersen SS, et al. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J. 2005;149(4):664–9.CrossRef Pedersen SS, et al. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J. 2005;149(4):664–9.CrossRef
30.
go back to reference Pedersen SS, et al. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation. Europace. 2010;12:1119–26.CrossRef Pedersen SS, et al. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation. Europace. 2010;12:1119–26.CrossRef
31.
go back to reference Zimet GD, et al. Psychometric characteristics of the multidimensional scale of perceived social support. J Pers Assess. 1990;55(3–4):610–7.CrossRef Zimet GD, et al. Psychometric characteristics of the multidimensional scale of perceived social support. J Pers Assess. 1990;55(3–4):610–7.CrossRef
32.
go back to reference Arestedt K, et al. A psychometric evaluation of the four-item version of the control attitudes scale for patients with cardiac disease and their partners. Eur J Cardiovasc Nurs. 2015;14(4):317–25.CrossRef Arestedt K, et al. A psychometric evaluation of the four-item version of the control attitudes scale for patients with cardiac disease and their partners. Eur J Cardiovasc Nurs. 2015;14(4):317–25.CrossRef
33.
go back to reference Moser DK, et al. Impact of anxiety and perceived control on in-hospital complications after acute myocardial infarction. Psychosom Med. 2007;69(1):10–6.CrossRef Moser DK, et al. Impact of anxiety and perceived control on in-hospital complications after acute myocardial infarction. Psychosom Med. 2007;69(1):10–6.CrossRef
34.
go back to reference Thylen I, et al. Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator. Eur J Cardiovasc Nurs. 2014;13(2):142–51.CrossRef Thylen I, et al. Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator. Eur J Cardiovasc Nurs. 2014;13(2):142–51.CrossRef
35.
go back to reference Börjesson-Hansson A, et al. One-month prevalence of mental disorders in a population sample of 95-year-olds. Am J Geriatr Psychiatry. 2011;19(3):284–91.CrossRef Börjesson-Hansson A, et al. One-month prevalence of mental disorders in a population sample of 95-year-olds. Am J Geriatr Psychiatry. 2011;19(3):284–91.CrossRef
36.
go back to reference Cutitta KE, et al. Shocktivity: ability and avoidance of daily activity behaviors in ICD patients. J Cardiopulm Rehabil Prev. 2014;34:241–7.CrossRef Cutitta KE, et al. Shocktivity: ability and avoidance of daily activity behaviors in ICD patients. J Cardiopulm Rehabil Prev. 2014;34:241–7.CrossRef
37.
go back to reference Sears SF, et al. Examination of the differential impacts of antitachycardia pacing vs. shock on patient activity in the EMPIRIC study. Europace. 2015;17:417–23.CrossRef Sears SF, et al. Examination of the differential impacts of antitachycardia pacing vs. shock on patient activity in the EMPIRIC study. Europace. 2015;17:417–23.CrossRef
38.
go back to reference Kramer DB, et al. Patient activity and survival following implantable cardioverter-defibrillator implantation: the ALTITUDE activity study. J Am Heart Assoc. 2015;4:e001775.PubMedPubMedCentral Kramer DB, et al. Patient activity and survival following implantable cardioverter-defibrillator implantation: the ALTITUDE activity study. J Am Heart Assoc. 2015;4:e001775.PubMedPubMedCentral
39.
go back to reference Fluur C, et al. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis. J Adv Nurs. 2014;70(8):1758–69.CrossRef Fluur C, et al. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis. J Adv Nurs. 2014;70(8):1758–69.CrossRef
40.
go back to reference van der Wal MH, et al. Heart failure patients' future expectations and their association with disease severity, quality of life, depressive symptoms and clinical outcomes. Int J Clin Pract. 2016;70(6):469–76.CrossRef van der Wal MH, et al. Heart failure patients' future expectations and their association with disease severity, quality of life, depressive symptoms and clinical outcomes. Int J Clin Pract. 2016;70(6):469–76.CrossRef
41.
go back to reference Goonewardene M, et al. Cardioverter defibrillator implantation and generator replacement in the octogenarian. Europace. 2015;17:409–16.CrossRef Goonewardene M, et al. Cardioverter defibrillator implantation and generator replacement in the octogenarian. Europace. 2015;17:409–16.CrossRef
42.
go back to reference Dodson JA, et al. Patient preferences for deactivation of implantable cardioverter defibrillators. JAMA Intern Med. 2013;173(3):377–8.CrossRef Dodson JA, et al. Patient preferences for deactivation of implantable cardioverter defibrillators. JAMA Intern Med. 2013;173(3):377–8.CrossRef
Metadata
Title
Octo- and nonagenarians’ outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study
Authors
Ingela Thylén
Debra K. Moser
Anna Strömberg
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2018
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-018-0942-9

Other articles of this Issue 1/2018

BMC Geriatrics 1/2018 Go to the issue